FDA Risk Communication Panel Advises Targeted Messages To Induce "Right Sort Of Worry"
This article was originally published in The Gray Sheet
Executive Summary
FDA's Risk Communication Advisory Committee discussed how FDA should communicate with disadvantaged populations, and offered thoughts on whether and how FDA should convey uncertainty in its risk communications.